Centiva Capital »

Terns Pharmaceuticals shares owned by Centiva Capital

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 314k 52.72

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors (TSLA)
Apple (AAPL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr China Lg-cap Etf (FXI)
Ishares Silver Tr Ishares Call Option (SLV)
Spdr Series Trust State Street Spd (KRE)

View all positions for Centiva Capital

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals